Signos announced that it raised $20 million in a Series B round to support its AI-powered continuous glucose monitor (CGM) technology. San Francisco-based Signos develops a comprehensive metabolic health platform. It includes a proprietary AI engine with a CGM to provide real-time data and recommendations for weight management. Signos aims for its metabolic-led solution to […]